Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...They can’t refinance it on a like-for-like basis. But they have the money to refinance it and get more time. I think that is really the story,” said Ramzi Kattan at Moody’s Ratings....
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...“People say that the planning system isn’t responsive....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant pursues acquisitions to bolster its medical technology arm....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...“It won’t go down, but it won’t go up,” says Steve, who chose a 25-year loan and who asked the FT not to use his real name....
...I’m Rob Armstrong in New York and I’m joined today by Josh Oliver in London....
...Michela Tindera Oliver tried to interview him as he reported on this story for the FT, but Eshelman said he couldn’t comment on an active case....
...And while summary statistics don’t tell especially colourful stories, they do suggest their outline....
...Oliver Roeder is the FT’s US senior data journalist Cartography by Steven Bernard and Sam Learner....
...Lord Eric Pickles, chair of the Advisory Committee on Business Appointments, reported the breach in a letter to deputy prime minister Oliver Dowden on Friday....
...“When I inherited the money, my instinct was, like, ‘I shouldn’t have this’,” he says....
...“We can’t build houses,” said Clare Miller, chief executive of Clarion, the UK’s largest housing association, which manages 125,000 homes....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...I can’t promise but, to me, [the pain franchise] looks like [CF] in 2012.”...
...Oliver Leith cheerfully maintains that he writes music the wrong way. “My approach is totally magpie-ish. Anything goes....
...However, Johnson avoided censure. Deputy prime minister Oliver Dowden told the appointments watchdog that it would be “disproportionate to undertake further action”....
...“I don’t know what to think about my exhibition, because I haven’t seen it yet....
...oliver.ralph@ft.com...
...But the term has so many emotional connotations that most people don’t link it to delivering business value,” he says....
...Spravato, a nasal spray based on a molecule from the psychedelic drug ketamine used to treat depression, already ranks as Johnson & Johnson’s fastest-growing product....
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
...If it is the case that we can’t lawfully in accordance with the act do so, of course we won’t supply those arms.”...
...Greg Johnson, an analyst at Shore Capital, said: “I struggle to see why it’s a great achievement to move out of markets you either weren’t ever really in or shouldn’t have been in the first place”....
International Edition